Skip to content
DataLookout
Menu

LOVENCT05208567

London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Aug 2, 2026 to Aug 2, 2028
    • Eligibility criteria expanded, about 2 words
    • Study completion pushed from Sep 2, 2026 to Sep 2, 2028
    • Collaborators: details revised at 1 of 1 entry
  2. Notable Primary completion date: Aug 2, 2025 to Aug 2, 2026
    • Study completion date: Sep 2, 2025 to Sep 2, 2026
    v6
  3. Notable Primary completion date: Aug 2, 2024 to Aug 2, 2025
    • Study completion date: Sep 2, 2024 to Sep 2, 2025
    v5
  4. Notable Primary completion date: Nov 2023 to Aug 2, 2024
    • Study completion date: Apr 2024 to Sep 2, 2024
    v4
  5. Minor Start date changed from estimate of Jan 2023 to Mar 14, 2023v3
  6. Notable Start date: Apr 2022 to Jan 2023v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Number of participants within a North East London community over the age of 65yrs old with Valvular Heart Disease, as assessed by Cardiac Ultrasound
Timeframe: 12 months
Number of participants within a North East London community over the age of 65yrs old with Left Ventricular Systolic Dysfunction as assessed by Cardiac Ultrasound
Timeframe: 12 months
Diagnostic accuracy in identifying heart valve disease or left ventricular systolic dysfunction using abbreviated echocardiography following training protocols.
Timeframe: 12 months

Arms and interventions

Diagnostic tests: Echocardiogram

Sites

1 site in 1 country

  • St Bartholomews HospitalLondon, United Kingdom